Veracode, the global leader in application risk management, today announced significant platform innovations introduced through the second half of 2025. Headlining the release is Package Firewall, an ...
– Positive, updated Phase 2 SOLSTICE data showed combination of tobevibart and elebsiran is well tolerated and achieved undetectable HDV RNA in 88% of chronic hepatitis delta participants evaluable at ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果